Pharmacokinetics in adults (≈ 70 kg) demonstrates a twocompartment model and exhibits linear pharmacokinetics in the 0.2–0.7 μg/kg/hr dosing range. Dexmedetomidine exhibits rapid distribution ...
Hosted on MSN3mon
Revolutionary obesity and diabetes treatment burns energy and reduces appetite without side effectsLong-acting pharmacotherapies targeting incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) have revolutionized treatments for obesity and ...
Among other topics, the teaching covers individual factors affecting pharmacotherapies, such as associated diseases, drug interaction and pharmacogenetics, as well as the application of ...
“These findings advance our global understanding of MD and reveal biological targets that may be used to target and develop pharmacotherapies addressing the unmet need for effective treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results